Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells

Journal of Neuroscience Research

Volumn 78, Issue 3, 2004, Pages 371-382

  Valerio, Alessandra ^a,d   Ferrario, Marina ^a   Martinez, Fernando O ^b   Locati, Massimo ^b,c   Ghisi, Valentina ^a   Bresciani, Laura Grazia ^a   Mantovani, Alberto ^a,b   Spano, PierFranco ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Division of Pharmacology   (Italy)

Author keywords

Chemokines; DNA array; Human neurons; Transcriptional profile

Indexed keywords

CHEMOKINE; MESSENGER RNA; RANTES; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPTOGENESIS; UNINDEXED SEQUENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL COUNT; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES, CC; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-JUN; RANTES; RECEPTORS, CCR5; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 8444253035     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20250     Document Type: Article

References (52)

1. Andreasson KI, Kaufmann WE. 2002. Role of immediate early gene expression in cortical morphogenesis and plasticity. Results Probl Cell Differ 39:113-137.
2. Angley C, Kumar M, Dinsio KJ, Hall AK, Siegel RE. 2003. Signaling by bone morphogenetic proteins and Smad1 modulates the postnatal differentiation of cerebellar cells. J Neurosci 23:260-268.
3. Arakawa Y, Bito H, Furuyashiki T, Tsuji T, Takemoto-Kimura S, Kimura K, Nozaki K, Hashimoto N, Narumiya S. 2003. Control of axon elongation via an SDF-1alpha/Rho/mDia pathway in cultured cerebellar granule neurons. J Cell Biol 28:381-391.
4. Asensio VC, Campbell IL. 1999. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 22:504-512.
5. Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Maysushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A, Schall T, Tsang M, Thorpe R, Van Damme J, Wadhwa M, Yoshie O, Zlotnik A, Zoon K. 2002. IUIS/WHO Subcommittee on Chemokine Nomenclature. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068.
6. Bacon KB, Harrison JK. 2000. Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J Neuroimmunol 104:92-97.
7. Bajetto A, Bonavia R, Barbero S, Schettini G. 2002. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 82:1311-1329.
8. Bakhiet M, Mousa A, Seiger A, Andersson J. 2002. Constitutive and inflammatory induction of alpha and beta chemokines in human first trimester forebrain astrocytes and neurons. Mol Immunol 38:921-929.
9. Bamforth SD, Braganca J, Eloranta JJ, Murdoch JN, Marques FI, Kranc KR, Farza H, Henderson DJ, Hurst HC, Bhattacharya S. 2001. Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat Genet 29:469-474.
10. Biber K, Zuurman MW, Dijkstra IM, Boddeke HW. 2002. Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol 2:63-68.
11. Bolin LM, Murray R, Lukacs NW, Stricter RM, Kunkel SL, Schall TJ, Bacon KB. 1998. Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol 81:49-57.
12. Bonecchi R, Facchetti F, Dusi S, Luini W, Lissandrini D, Simmelink M, Locati M, Bernasconi S, Allavena P, Brandt E, Rossi F, Mantovani A, Sozzani S. 2000. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J Immunol 164:3862-3869.
13. Britanova O, Lukyanov S, Gruss P, Tarabykin V. 2002. The mouse Laf4 gene: exon/intron organization, cDNA sequence, alternative splicing, and expression during central nervous system development. Genomics 80:31-37.
14. Bruno V, Copani A, Besong G, Scoto G, Nicoletti F. 2000. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 399:117-121.
15. Cabrera C, Witvrouw M, Gutierrez A, Clotet B, Kuipers ME, Swart PJ, Meijer DK, Desmyter J, De Clercq E, Este JA. 1999. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4. AIDS Res Hum Retroviruses 15:1535-1543.
16. Chalasani SH, Baribaud F, Coughlan CM, Sunshine MJ, Lee VM, Doms RW, Littman DR, Raper JA. 2003. The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J Neurosci 23:4601-4612.
17. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736.
18. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1 (beta), and RANTES. J Leukoc Biol 60:147-152.
19. Coughlan CM, McManus CM, Sharron M, Gao Z, Murphy D, Jaffer S, Choe W, Chen W, Hesselgesser J, Gaylord H, Kalyuzhny A, Lee VM, Wolf B, Doms RW, Kolson DL. 2000. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97:591-600.
20. Eichholtz-Wirth H, Fritz E, Wolz L. 2003. Overexpression of the "silencer of death domain," SODD/BAG-4, modulates both TNFR1- and CD95-dependent cell death pathways. Cancer Lett 194:81-89.
21. Felder B, Stegmann K, Schultealbert A, Geller F, Strehl E, Ermert A, Koch MC. 2002. Evaluation of BMP4 and its specific inhibitor NOG as candidates in human neural tube defects (NTDs). Eur J Hum Genet 10:753-756.
22. Fu WY, Wang JH, Ip NY. 2002. Expression of Cdk5 and its activators in NT2 cells during neuronal differentiation. J Neurochem 81:646-654.
23. Glabinski AR, Ransohoff RM. 1999. Chemokines and chemokine receptors in CNS pathology. J Neurovirol 5:3-12.
24. Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, Lalli G, Witherden AS, Hummerich H, Nicholson S, Morgan PJ, Oozageer R, Priestley JV, Averill S, King VR, Ball S, Peters J, Toda T, Yamamoto A, Hiraoka Y, Augustin M, Korthaus D, Wattler S, Wabnitz P, Dickneite C, Lampel S, Boehme F, Peraus G, Popp A, Rudelius M, Schlegel J, Fuchs H, Hrabe de Angelis M, Schiavo G, Shima DT, RUSS AP, Stumm G, Martin JE, Fisher EM. 2003. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300:808-812.
25. Humbert S, Dhavan R, Tsai L. 2000. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. J Cell Sci 113:975-983.
26. Inagaki N, Chihara K, Arimura N, Menager C, Kawano Y, Matsuo N, Nishimura T, Amano M, Kaibuchi K. 2001. CRMP-2 induces axons in cultured hippocampal neurons. Nat Neurosci 4:781-782.
27. Karagogeos D. 2003. Neural GP1-anchored cell adhesion molecules. Front Biosci 8:1304-1320.
28. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH. 2001. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771.
29. Lambert de Rouvroit C, Goffinet AM. 2001. Neuronal migration. Mech Dev 105:47-56.
30. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascano J, Tokito M, Van Winkle T, Howland DS, Holzbaur EL. 2002. Disruption of dynein/ dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34:715-727.
31. Laub F, Aldabe R, Friedrich V Jr, Ohnishi S, Yoshida T, Ramirez F. 2001. Developmental expression of mouse Kruppel-like transcription factor KLF7 suggests a potential role in neurogenesis. Dev Biol 233:305-318.
32. Leung T, Ng Y, Cheong A, Ng CH, Tan I, Hall C, Lim L. 2002. p80 ROKalpha binding protein is a novel splice variant of CRMP-1 which associates with CRMP-2 and modulates RhoA-induced neuronal morphology. FEBS Lett 532:445-449.
33. Li W, Cogswell CA, LoTurco JJ. 1998. Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. J Neurosci 18:8853-8862.
34. Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S, Bartfai T, Mantovani A. 2002. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 168:3557-3562.
35. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B. 1994. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 269:232-237.
36. Lu M, Grove EA, Miller RJ. 2002. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99:7090-7095.
37. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 95:9448-9453.
38. Mantovani A. 1999. The chemokine system: redundancy for robust outputs. Immunol Today 20:254-257.
39. McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu CM, Russell CG, Chittur KK. 2001. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 98:8955-8960.
40. Mennicken F, Maki R, de Souza EB, Quirion R. 1999. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20:73-78.
41. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95:14500-14505.
42. Mikule K, Gatlin JC, de la Houssaye BA, Pfenninger KH. 2002. Growth cone collapse induced by semaphorin 3A requires 12/15-lipoxygenase. J Neurosci 22:4932-4941.
43. Moser B, Loetscher P. 2001. Lymphocyte traffic control by chemokines. Nat Immunol 2:123-128.
44. Naif HM, Li S, Alali M, Sloane A, Wu L, Kelly M, Lynch G, Lloyd A, Cunningham AL. 1998. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 72:830-836.
45. Oh SB, Endoh T, Simen AA, Ren D, Miller RJ. 2002. Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 123:66-75.
46. Pleasure SJ, Page C, Lee VM. 1992. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12: 1802-1815.
47. Raff T, van der Giet M, Endemann D, Wiederholt T, Paul M. 1997. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 23:456-460.
48. Smith DS, Tsai LH. 2002. Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol 12:28-36.
49. Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M. 2002. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol Cell Neurosci 21:602-615.
50. Watts RJ, Hoopfer ED, Luo L. 2003. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38:871-885.
51. Zhu Y, Yu T, Zhang XC, Nagasawa T, Wu JY, Rao Y. 2002. Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci 5:719-720.
52. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599.